000 03824nam a22003855i 4500
001 303988
003 MX-SnUAN
005 20160429155845.0
007 cr nn 008mamaa
008 150903s2012 gw | o |||| 0|eng d
020 _a9783642246128
_99783642246128
024 7 _a10.1007/9783642246128
_2doi
035 _avtls000358065
039 9 _a201509030544
_bVLOAD
_c201405070225
_dVLOAD
_y201402191513
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC321-580
100 1 _aStanford, Clare.
_eeditor.
_9342710
245 1 0 _aBehavioral Neuroscience of Attention Deficit Hyperactivity Disorder and Its Treatment /
_cedited by Clare Stanford, Rosemary Tannock.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2012.
300 _axiv, 433 páginas 18 ilustraciones, 10 ilustraciones en color.
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aCurrent Topics in Behavioral Neurosciences,
_x1866-3370 ;
_v9
500 _aSpringer eBooks
505 0 _aFrom the contents: ADHD in children and adults: diagnosis and prognosis -- ADHD: Volumetry, Motor, and Oculomotor Functions -- Neurodevelopmental abnormalities in ADHD -- Intra-individual Variability in ADHD and its Implications for Research of Causal Links -- Hypothalamic – pituitary - adrenocortical function in Attention Deficit / Hyperactivity Disorder -- Brain Processes in Discounting: Consequences of Adolescent Methylphenidate Exposure -- Attention Deficit Hyperactivity Disorder and Substance Use Disorders -- Linking ADHD, impulsivity and drug abuse: a neuropsychological perspective -- Obesity and ADHD:  clinical and neurobiological implications -- Face Processing in Attention Deficit/Hyperactivity Disorder -- Quantitative and molecular genetics of ADHD -- Rodent models of ADHD -- Rat Models of ADHD.-  Epigenetics: Genetics versus Life Experiences -- Sexual differentiation of the brain and ADHD:  What is a sex difference in prevalence telling us?- ADHD: Current and future therapeutics -- The Four Causes of ADHD: A Framework.
520 _aThe Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder reviews the latest discoveries in research of ADHD.  There is a strong emphasis on translational science, with preclinical approaches suggesting new directions for development of new treatments.  Individual chapters describe how neuroimaging, neuroendocrine, genetic and behavioral studies use powerful research tools that are offering a completely new understanding of the factors that increase vulnerability to ADHD.  The clinical impact of co-morbid problems, especially obesity and substance misuse, are highlighted and explain what such problems can tell us about the etiology of ADHD, more generally.  Reviews of the pharmacology of established drug treatments for ADHD justify an exciting novel theory for their therapeutic actions and address questions about the effects of their long?term use.  This volume is aimed at both clinicians and basic scientists, who are interested in ADHD, giving students and established researchers an overview of the current status of the field and insight into topics that will be prominent in the future.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aTannock, Rosemary.
_eeditor.
_9342711
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9783642246111
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-642-24612-8
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c303988
_d303988